Real-time enrollment status for this gastroesophageal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:18 PM UTC
| NCT Number | NCT06469944 |
| Recruiting Status | Recruiting |
| Condition | Gastroesophageal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 18, 2026: Clinical trial NCT06469944 is currently recruiting participants. This phase1 study for gastroesophageal adenocarcinoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06469944 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06469944 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.